By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere took a 49 percent hit in its third quarter revenues year over year, the company reported after the close of the market on Wednesday.

For the three months ended Sept. 30, the company recorded revenues of $373,437, compared to $729,017 a year ago, short of Wall Street expectations, which had estimated $670,000 in revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.